BELX Bio-Pharmaceutical was selected to participate in the「 2022 SelectUSA Investment Summit 」

2022-06-26 Announcement

    BELX Bio-Pharmaceutical has been selected by Taiwan government's Department of Industrial Technology (DoIT) of the Ministry of Economic Affairs via a program, TREE, to represent the MedTech of the country at the SelectUSA Investment Summit.

    The SelectUSA Investment Summit is the highest-profile event organized by the U.S. Department of Commerce to promote foreign direct investment in the United States. The Summit attracts a wide range of senior government officials, corporate executives and industry leaders to engage in the latest business information. Through the Summit, companies will have the opportunity to interact with economic developers, service suppliers, industry experts and investors from all around the U.S. and learn actionable information on developing a workforce to understanding incentives.  Moreover, companies directly negotiate new business opportunities in the U.S.  BELX has been selected as Taiwanese representative and MedTech pitch presenter for two consecutive years.  SelectUSA is beneficial for foreign BELX to establish valuable partnerships and expand our business in the U.S. in the future.